Related Experiment Video
Updated: Apr 7, 2026
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
Detection of low-level DNA mutation by ARMS-blocker-Tm PCR
Shoufang Qu1, Licheng Liu2, Shuzhen Gan3
1Division of in Vitro Diagnostic Reagents, National Institutes for Food and Drug Control (NIFDC), Beijing 100050, China.
Background:
Low-level DNA mutations play important roles in cancer prognosis and treatment. However, most existing methods for the detection of low-level DNA mutations are insufficient for clinical applications because of the high background of wild-type DNA.
Design And Method:
In this study, a novel assay based on Tm-dependent inhibition of wild type template amplification was developed. The defining characteristic of this assay is an additional annealing step was introduced into the ARMS-blocker PCR. The temperature of this additional annealing step is equal to the Tm of the blocker. Due to this additional annealing step, the blocker can preferentially and specifically bind the wild-type DNA. Thus, the inhibition of wild type template is realized and the mutant DNA is enriched.
Results:
The sensitivity of this assay was between 10(-4) and 10(-5), which is approximately 5 to 10 times greater than the sensitivity of the assay without the additional annealing step. To evaluate the performance of this assay in detecting K-ras mutation, we analyzed 100 formalin-fixed paraffin-embedded (FFPE) specimens from colorectal cancer patients using this new assay and Sanger sequencing. Of the clinical samples, 27 samples were positive for K-ras mutation by both methods.
Conclusions:
Our results indicated that this new assay is a highly selective, convenient, and economical method for detecting rare mutations in the presence of higher concentrations of wild-type DNA.
Insights
A novel assay enhances detection of rare DNA mutations by preferentially inhibiting wild-type DNA amplification. This method improves sensitivity for cancer mutation analysis in clinical samples.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Low-level DNA mutations are critical for cancer prognosis and treatment.
- Existing detection methods struggle with high wild-type DNA background, limiting clinical use.
Purpose of the Study:
- To develop a novel assay for sensitive detection of low-level DNA mutations.
- To overcome limitations of existing methods in high wild-type DNA backgrounds.
Main Methods:
- Developed a novel assay using Tm-dependent inhibition of wild-type template amplification.
- Incorporated an additional annealing step in ARMS-blocker PCR at the blocker's Tm.
- This step enables preferential binding of the blocker to wild-type DNA, inhibiting its amplification and enriching mutant DNA.
Main Results:
- Achieved a sensitivity of 10(-4) to 10(-5), 5-10 times higher than assays without the additional annealing step.
- Successfully detected K-ras mutations in 27 out of 100 colorectal cancer FFPE specimens.
- Corroborated results with Sanger sequencing.
Conclusions:
- The new assay is highly selective, convenient, and economical for rare mutation detection.
- Demonstrated effectiveness in identifying mutations amidst high concentrations of wild-type DNA.
- Offers a promising tool for clinical applications in cancer mutation analysis.
More Related Videos
10:41Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
08:23Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
Published on: September 25, 2018
